Suvoda has launched a purpose-built software platform that brings proven tech innovation to clinical trial management.

The new low-code/no-code platform has been designed to provide a seamless way for drug trial sponsors and sites to manage complex, mission-critical, and time-sensitive moments on the patient journey.

It minimises the friction across the eConsent, IRT, and eCOA user experience for sites, CROs, sponsors, and patients.

The extensible software platform simplifies integrations and strengthens data governance, which enables studies to be implemented more efficiently and with less downtime risk.

With smooth user workflows, the Suvoda platform offers a consistent interface across the company’s IRT, eConsent, and eCOA solutions.

This allows clinicians to move seamlessly from one task to the other, reducing the workload and training.

The low-code/no-code technology of the platform helps to streamline the study start-up and mid-study changes.

The unified platform allows all the site and patient data across eCOA, eConsent, and IRT to be centrally collected, managed, stored, and analysed.

Suvoda CEO Jagath Wanninayake said: “Clinical trials are increasingly complex, expensive, and fraught with challenges that are affecting trial execution, mid-study changes, data silos, trial delays, and more.

“To meet these challenges, our team organically built a platform upon which we are delivering the next generation of clinical trial applications designed to handle complexity with ease and reduce overall risk throughout trials.

“Our goal is always for sponsors and site users to spend less time with technology and more time on what is most important to them…uncovering scientific breakthroughs and focusing on the patients we all ultimately serve.”

In December last year, the company launched the electronic clinical outcome assessments (eCOA) design toolkit.